Swapnil Bhargava
Hoofd Techniek/Wetenschap/O&O bij CG ONCOLOGY, INC.
Profiel
Swapnil Bhargava is currently the Chief Technical Officer at CG Oncology, Inc. He previously worked as the SVP-CMC Development & GMP Manufacturing at AbCellera Biologics, Inc. and as the VP-Drug Substance Process Development at Seagen Inc. Dr. Bhargava holds a doctorate degree from the University of Maryland and a graduate degree from the Indian Institute of Technology Delhi.
Actieve functies van Swapnil Bhargava
| Bedrijven | Functie | Begin |
|---|---|---|
| CG ONCOLOGY, INC. | Hoofd Techniek/Wetenschap/O&O | 01-09-2023 |
Eerdere bekende functies van Swapnil Bhargava
| Bedrijven | Functie | Einde |
|---|---|---|
| SEAGEN INC. | Corporate Officer/Principal | - |
| ABCELLERA BIOLOGICS INC. | Corporate Officer/Principal | - |
Opleiding van Swapnil Bhargava
| University of Maryland | Doctorate Degree |
| Indian Institute of Technology Delhi | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| CG ONCOLOGY, INC. | Health Technology |
| ABCELLERA BIOLOGICS INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Seagen Inc.
 Seagen Inc. Pharmaceuticals: MajorHealth Technology Seagen Inc. is a biotechnology company, which engages in the development and commercialization of targeted therapies for the treatment of cancer. It also focuses on the advancement of therapies for solid tumors and blood-related cancers. Its products include Adcetris, Padcev, Tivdak, and Tukysa. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA. | Health Technology |
